Drugs / AP09004
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00918177 | Jul 2009 → Oct 2012 | Parkinson disease | Intec Pharma Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AP09004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00918177 ↗ |
| Route | Oral | “multiple oral doses of AP09004” NCT00918177 ↗ |